Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma

NCT01328223 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT01328223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01328223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
Lead sponsor
China Medical University Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2010
Completion date
December 31, 2012
Enrollment
45 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma